Skip to main content
. 2020 Jun 13;2020:1807941. doi: 10.1155/2020/1807941

Table 4.

Laboratory parameters of CKD patients and control group.

CKD patients Control group
T0 T1 T0 vs T1 T0 T1 T0 vs T1
Creatinine (mg/dl) 2.5 ± 1.4a 2.5 ± 1.5a nsb 0.8 ± 0.1a 0.8 ± 0.1a nsb
e-GFR (ml/min/1.72 m2) 32.0 ± 18.3a 34.1 ± 21.4a nsb 93.5 ± 20.4a 92.1 ± 14.4a nsb
Albuminuria (mg/dl) 424.5 ± 614.5a 451.1 ± 651.9a nsb 2.5 ± 3.9a 12.2 ± 28.1a nsb
Azotaemia (mg/dl) 85.0 ± 34.4a 80.5 ± 30.8a nsb 32.6 ± 8.0a 34.8 ± 4.7a nsb
Albumin (g/dl) 4.34 ± 0.30a 4.20 ± 0.35a nsb 4.29 ± 0.2a 4.35 ± 0.3a nsb
Sodium (mEq/l) 139.78 ± 3.2a 140.1 ± 2.6a nsb 141.7 ± 2.6a 140.0 ± 2.9a nsb
Potassium (mEq/l) 4.8 ± 0.6a 4.8 ± 0.7a nsb 4.5 ± 1.0a 4.7 ± 0.6a nsb
Calcium (mg/dl) 9.7 ± 0.8a 9.7 ± 0.7a nsb 9.4 ± 0.4a 9.7 ± 0.4a nsb
Phosphorus (mg/dl) 3.6 ± 0.8a 3.7 ± 0.8a nsb 3.5 ± 0.5a 3.6 ± 0.5a nsb
TC (mg/dl) 185.4 ± 47.1a 176.4 ± 44.7a p = 0.044b 205.8 ± 60.2a 214 ± 15.7a nsb
HDL-C (mg/dl) 51.5 ± 12.5a 52.1 ± 10.9a nsb 50.3 ± 13.5a 52.9 ± 11.9a nsb
Triglycerides (mg/dl) 136.3 ± 59.7a 133.8 ± 75.2a nsb 100.5 ± 46.2a 108.9 ± 66.2a nsb
LDL-C (mg/dl) 107.9 ± 39.5a 100.9 ± 40.3a nsb 127.2 ± 43.2a 142.6 ± 12.9a nsb
Sideremia (μg/dl) 79.4 ± 29.9a 82.0 ± 39.7a nsb 89.9 ± 25.5a 85.7 ± 20.7a nsb
Ferritin (ng/ml) 139 ± 131.2a 138.7 ± 129.3a nsb 195.2 ± 163.9a 179.4 ± 139.7a nsb
Transferrin (mg/dl) 247.4 ± 44.5a 244.7 ± 40a nsb 255.7 ± 39.6a 248.5 ± 34.7a nsb
Uric acid (mg/dl) 6.0 ± 1.2a 6.0 ± 1.4a nsb 5.1 ± 1.0a 4.9 ± 1.0a nsb
CRP (mg/l) 5.1 ± 9.8a 3.6 ± 7.2a p = 0.048b 0.8 ± 0.1a 0.8 ± 0.1a nsb
ESR (mm/h) 48.3 ± 23.2a 40.7 ± 22.6a p = 0.019b 93.5 ± 20.4a 92.1 ± 14.4a nsb

aData expressed as mean ± standard deviation; bapplied test: t-test for paired data. Abbreviations: e-GFR: estimated glomerular filtration rate; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate. Values of p ≤ 0.05 are considered statistically significant.